Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis

被引:85
作者
Ji, WR
Barrientos, LG
Llinás, M
Gray, H
Villarreal, X
DeFord, ME
Castellino, FJ
Kramer, RA
Trail, PA
机构
[1] Bristol Myers Squibb Pharmaceut Inc, Dept Oncol Drug Discovery, Princeton, NJ 08543 USA
[2] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA
[3] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA
关键词
D O I
10.1006/bbrc.1998.8825
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiogenesis is a multi-step process that includes endothelial cell proliferation, migration, basement membrane degradation, and new lumen organization. Angiostatin, an internal fragment of plasminogen comprising the first four triple disulfide-linked kringle structures, is one of the most potent endogenous angiogenesis inhibitors described to date. The kringle 5 domain of plasminogen, which shares high sequence homology with the four kringles of angiostatin, was previously shown to antagonize endothelial cell growth. We now describe that the recombinant kringle 5 of human plasminogen inhibits endothelial cell migration with an IC50 (concentration for half maximal inhibition) of approximately 500 nM. We demonstrate that the lysine-binding sites of kringle 5 may not be involved in its anti-migratory activities. The anti-migratory activity of kringle 5 is similar to that of angiostatin. Kringle 5 also shows selective inhibition on endothelial cells as opposed to other cell types. Relative to its native form, reduced kringle 5 displays a significant increase in anti-migratory activity, implying that the kringle conformation may shield kringle 5 from effectively interacting with endothelial cells. This report thus constitutes the first demonstration that kringle 5 of plasminogen is a selective inhibitor for endothelial cell migration. (C) 1998 Academic Press.
引用
收藏
页码:414 / 419
页数:6
相关论文
共 29 条
[1]  
BRATTAIN MG, 1981, ONCODEV BIOL MED, V2, P355
[2]   Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth [J].
Cao, YH ;
Chen, A ;
An, SSA ;
Ji, RWD ;
Davidson, D ;
Cao, YM ;
Llinas, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (36) :22924-22928
[3]   Kringle domains of human angiostatin - Characterization of the anti-proliferative activity on endothelial cells [J].
Cao, YH ;
Ji, RW ;
Davidson, D ;
Schaller, J ;
Marti, D ;
Sohndel, S ;
McCance, SG ;
OReilly, MS ;
Llinas, M ;
Folkman, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29461-29467
[4]   Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties [J].
Chang, Y ;
Zajicek, J ;
Castellino, FJ .
BIOCHEMISTRY, 1997, 36 (25) :7652-7663
[5]  
DEPOLI P, 1982, BLOOD, V73, P361
[6]   LONG-TERM CULTURE OF CAPILLARY ENDOTHELIAL-CELLS [J].
FOLKMAN, J ;
HAUDENSCHILD, CC ;
ZETTER, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (10) :5217-5221
[7]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[8]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[9]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[10]   The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin [J].
Gately, S ;
Twardowski, P ;
Stack, MS ;
Cundiff, DL ;
Grella, D ;
Castellino, FJ ;
Enghild, J ;
Kwaan, HC ;
Lee, F ;
Kramer, RA ;
Volpert, O ;
Bouck, N ;
Soff, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10868-10872